The Patent Finder

Bioinvent International AB

Also on record
Records under this name other than the patents Bioinvent International AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.

Back to Bioinvent International AB

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 12,291,569Novel Antibodies and Nucleotide Sequences, and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,758,749Biological materials and uses thereof
Lapsed on the fee record
Ended Jun 24, 2026 · USPTO record
Lapsed on the fee recordEnded Jun 24, 2026USPTO record
US 9,803,013Biological materials and uses thereof
Lapsed on the fee record
Ended Oct 31, 2025 · USPTO record
Lapsed on the fee recordEnded Oct 31, 2025USPTO record
US 10,351,970Method for screening anti-ligand libraries for identifying anti-ligands specific for differentially and infrequently expressed ligands
Term ended
Term ended Jul 12, 2024 · USPTO record
Term endedTerm ended Jul 12, 2024USPTO record
US 9,266,952Antibodies against ROR1 and uses thereof
Lapsed on the fee record
Ended Feb 23, 2024 · USPTO record
Lapsed on the fee recordEnded Feb 23, 2024USPTO record
US 9,150,647Biological inhibitors of ROR1 capable of inducing cell death
Formerly held
Lapsed on the fee record
Ended Oct 6, 2023 · USPTO record
Lapsed on the fee recordEnded Oct 6, 2023USPTO record
US 7,943,744ICAM-1 binding antibodies
Lapsed on the fee record
Ended May 17, 2023 · USPTO record
Lapsed on the fee recordEnded May 17, 2023USPTO record
US 6,495,321Method for in vitro molecular evolution of protein function
Formerly held
Term ended
Ended no later than Apr 6, 2020 · USPTO record
Term endedEnded no later than Apr 6, 2020USPTO record
US 7,432,083Method for in vitro molecular evolution of protein function
Term ended
Term ended Jan 19, 2019 · USPTO record
Term endedTerm ended Jan 19, 2019USPTO record
US 7,153,655Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence
Lapsed on the fee record
Ended Dec 26, 2018 · USPTO record
Lapsed on the fee recordEnded Dec 26, 2018USPTO record
10 of 19 patents shown.
Pro members see all 19.
Pro members: see all 19 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited